nodes	percent_of_prediction	percent_of_DWPC	metapath
Paricalcitol—CYP3A4—Rosuvastatin—atherosclerosis	0.0628	0.211	CbGbCtD
Paricalcitol—CYP3A4—Ezetimibe—atherosclerosis	0.0628	0.211	CbGbCtD
Paricalcitol—CYP3A4—Simvastatin—atherosclerosis	0.0584	0.196	CbGbCtD
Paricalcitol—CYP3A4—Lovastatin—atherosclerosis	0.0571	0.192	CbGbCtD
Paricalcitol—CYP3A4—Pravastatin—atherosclerosis	0.0571	0.192	CbGbCtD
Paricalcitol—VDR—leg—atherosclerosis	0.0185	0.287	CbGeAlD
Paricalcitol—VDR—hindlimb—atherosclerosis	0.0165	0.256	CbGeAlD
Paricalcitol—VDR—appendage—atherosclerosis	0.0142	0.22	CbGeAlD
Paricalcitol—Ergocalciferol—CYP27A1—atherosclerosis	0.0078	0.48	CrCbGaD
Paricalcitol—Cholecalciferol—CYP27A1—atherosclerosis	0.00591	0.364	CrCbGaD
Paricalcitol—VDR—connective tissue—atherosclerosis	0.00404	0.0627	CbGeAlD
Paricalcitol—UGT1A4—liver—atherosclerosis	0.00395	0.0612	CbGeAlD
Paricalcitol—VDR—cardiovascular system—atherosclerosis	0.00352	0.0545	CbGeAlD
Paricalcitol—VDR—adipose tissue—atherosclerosis	0.0031	0.0481	CbGeAlD
Paricalcitol—Calcipotriol—MPO—atherosclerosis	0.00253	0.156	CrCbGaD
Paricalcitol—CYP3A4—Farnesoid X Receptor  Pathway—CYP7A1—atherosclerosis	0.00126	0.00516	CbGpPWpGaD
Paricalcitol—UGT1A4—Biological oxidations—CYP27A1—atherosclerosis	0.00123	0.00504	CbGpPWpGaD
Paricalcitol—UGT1A4—Metapathway biotransformation—CYP27A1—atherosclerosis	0.00121	0.00497	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptor transcription pathway—ESR1—atherosclerosis	0.0012	0.0049	CbGpPWpGaD
Paricalcitol—CYP3A4—Aflatoxin B1 metabolism—GSTM1—atherosclerosis	0.00115	0.00473	CbGpPWpGaD
Paricalcitol—Hypoaesthesia—Pravastatin—atherosclerosis	0.00113	0.003	CcSEcCtD
Paricalcitol—Pharyngitis—Pravastatin—atherosclerosis	0.00113	0.003	CcSEcCtD
Paricalcitol—Chills—Simvastatin—atherosclerosis	0.00113	0.003	CcSEcCtD
Paricalcitol—Muscle spasms—Lovastatin—atherosclerosis	0.00113	0.00299	CcSEcCtD
Paricalcitol—Infection—Rosuvastatin—atherosclerosis	0.00112	0.00297	CcSEcCtD
Paricalcitol—VDR—Retinoic acid receptors-mediated signaling—MAPK8—atherosclerosis	0.00112	0.00459	CbGpPWpGaD
Paricalcitol—Alopecia—Simvastatin—atherosclerosis	0.00111	0.00295	CcSEcCtD
Paricalcitol—Back pain—Ezetimibe—atherosclerosis	0.00111	0.00295	CcSEcCtD
Paricalcitol—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00111	0.00293	CcSEcCtD
Paricalcitol—Muscle spasms—Ezetimibe—atherosclerosis	0.00111	0.00293	CcSEcCtD
Paricalcitol—Mental disorder—Simvastatin—atherosclerosis	0.0011	0.00292	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.00109	0.00448	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptor transcription pathway—PPARG—atherosclerosis	0.00109	0.00447	CbGpPWpGaD
Paricalcitol—Ill-defined disorder—Lovastatin—atherosclerosis	0.00109	0.00288	CcSEcCtD
Paricalcitol—Eye disorder—Niacin—atherosclerosis	0.00108	0.00286	CcSEcCtD
Paricalcitol—Dysgeusia—Simvastatin—atherosclerosis	0.00107	0.00285	CcSEcCtD
Paricalcitol—Angioedema—Lovastatin—atherosclerosis	0.00107	0.00284	CcSEcCtD
Paricalcitol—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00107	0.00283	CcSEcCtD
Paricalcitol—VDR—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—atherosclerosis	0.00106	0.00436	CbGpPWpGaD
Paricalcitol—Anaemia—Ezetimibe—atherosclerosis	0.00106	0.00282	CcSEcCtD
Paricalcitol—Malaise—Lovastatin—atherosclerosis	0.00106	0.0028	CcSEcCtD
Paricalcitol—Cardiac disorder—Pravastatin—atherosclerosis	0.00106	0.0028	CcSEcCtD
Paricalcitol—Muscle spasms—Simvastatin—atherosclerosis	0.00105	0.00279	CcSEcCtD
Paricalcitol—Vertigo—Lovastatin—atherosclerosis	0.00105	0.00279	CcSEcCtD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—IL10—atherosclerosis	0.00105	0.00431	CbGpPWpGaD
Paricalcitol—Angioedema—Ezetimibe—atherosclerosis	0.00105	0.00278	CcSEcCtD
Paricalcitol—Angiopathy—Niacin—atherosclerosis	0.00105	0.00278	CcSEcCtD
Paricalcitol—Leukopenia—Lovastatin—atherosclerosis	0.00105	0.00278	CcSEcCtD
Paricalcitol—VDR—Direct p53 effectors—HSPA1B—atherosclerosis	0.00104	0.00427	CbGpPWpGaD
Paricalcitol—Chills—Niacin—atherosclerosis	0.00104	0.00275	CcSEcCtD
Paricalcitol—Malaise—Ezetimibe—atherosclerosis	0.00104	0.00275	CcSEcCtD
Paricalcitol—Arrhythmia—Niacin—atherosclerosis	0.00103	0.00274	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00103	0.00273	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.00103	0.00422	CbGpPWpGaD
Paricalcitol—Alopecia—Niacin—atherosclerosis	0.00102	0.00271	CcSEcCtD
Paricalcitol—Chills—Pravastatin—atherosclerosis	0.00102	0.00271	CcSEcCtD
Paricalcitol—Insomnia—Rosuvastatin—atherosclerosis	0.00102	0.00271	CcSEcCtD
Paricalcitol—Ill-defined disorder—Simvastatin—atherosclerosis	0.00102	0.0027	CcSEcCtD
Paricalcitol—Arrhythmia—Pravastatin—atherosclerosis	0.00102	0.0027	CcSEcCtD
Paricalcitol—Palpitations—Ezetimibe—atherosclerosis	0.00102	0.00269	CcSEcCtD
Paricalcitol—Paraesthesia—Rosuvastatin—atherosclerosis	0.00101	0.00269	CcSEcCtD
Paricalcitol—Anaemia—Simvastatin—atherosclerosis	0.00101	0.00269	CcSEcCtD
Paricalcitol—Malnutrition—Niacin—atherosclerosis	0.00101	0.00267	CcSEcCtD
Paricalcitol—Alopecia—Pravastatin—atherosclerosis	0.00101	0.00267	CcSEcCtD
Paricalcitol—Cough—Ezetimibe—atherosclerosis	0.001	0.00266	CcSEcCtD
Paricalcitol—Angioedema—Simvastatin—atherosclerosis	0.001	0.00266	CcSEcCtD
Paricalcitol—Myalgia—Lovastatin—atherosclerosis	0.000998	0.00264	CcSEcCtD
Paricalcitol—Chest pain—Lovastatin—atherosclerosis	0.000998	0.00264	CcSEcCtD
Paricalcitol—Arthralgia—Lovastatin—atherosclerosis	0.000998	0.00264	CcSEcCtD
Paricalcitol—Anxiety—Lovastatin—atherosclerosis	0.000994	0.00264	CcSEcCtD
Paricalcitol—Dyspepsia—Rosuvastatin—atherosclerosis	0.000993	0.00263	CcSEcCtD
Paricalcitol—VDR—RXR and RAR heterodimerization with other nuclear receptor—TNF—atherosclerosis	0.000993	0.00407	CbGpPWpGaD
Paricalcitol—Hypertension—Ezetimibe—atherosclerosis	0.000992	0.00263	CcSEcCtD
Paricalcitol—Malaise—Simvastatin—atherosclerosis	0.000988	0.00262	CcSEcCtD
Paricalcitol—Tension—Niacin—atherosclerosis	0.000988	0.00262	CcSEcCtD
Paricalcitol—Discomfort—Lovastatin—atherosclerosis	0.000986	0.00261	CcSEcCtD
Paricalcitol—Vertigo—Simvastatin—atherosclerosis	0.000985	0.00261	CcSEcCtD
Paricalcitol—Leukopenia—Simvastatin—atherosclerosis	0.000981	0.0026	CcSEcCtD
Paricalcitol—Chest pain—Ezetimibe—atherosclerosis	0.000979	0.00259	CcSEcCtD
Paricalcitol—Myalgia—Ezetimibe—atherosclerosis	0.000979	0.00259	CcSEcCtD
Paricalcitol—Arthralgia—Ezetimibe—atherosclerosis	0.000979	0.00259	CcSEcCtD
Paricalcitol—VDR—Retinoic acid receptors-mediated signaling—MAPK3—atherosclerosis	0.000978	0.00401	CbGpPWpGaD
Paricalcitol—Nervousness—Niacin—atherosclerosis	0.000978	0.00259	CcSEcCtD
Paricalcitol—Dry mouth—Lovastatin—atherosclerosis	0.000976	0.00259	CcSEcCtD
Paricalcitol—Tension—Pravastatin—atherosclerosis	0.000972	0.00258	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000972	0.00258	CcSEcCtD
Paricalcitol—Dysgeusia—Pravastatin—atherosclerosis	0.00097	0.00257	CcSEcCtD
Paricalcitol—Muscle spasms—Niacin—atherosclerosis	0.000968	0.00257	CcSEcCtD
Paricalcitol—Discomfort—Ezetimibe—atherosclerosis	0.000967	0.00256	CcSEcCtD
Paricalcitol—Pain—Rosuvastatin—atherosclerosis	0.000965	0.00256	CcSEcCtD
Paricalcitol—Constipation—Rosuvastatin—atherosclerosis	0.000965	0.00256	CcSEcCtD
Paricalcitol—Confusional state—Lovastatin—atherosclerosis	0.000964	0.00256	CcSEcCtD
Paricalcitol—Nervousness—Pravastatin—atherosclerosis	0.000962	0.00255	CcSEcCtD
Paricalcitol—Dry mouth—Ezetimibe—atherosclerosis	0.000957	0.00254	CcSEcCtD
Paricalcitol—Muscle spasms—Pravastatin—atherosclerosis	0.000953	0.00253	CcSEcCtD
Paricalcitol—Infection—Lovastatin—atherosclerosis	0.00095	0.00252	CcSEcCtD
Paricalcitol—Confusional state—Ezetimibe—atherosclerosis	0.000946	0.00251	CcSEcCtD
Paricalcitol—UGT1A4—Phase II conjugation—GSTM1—atherosclerosis	0.000939	0.00385	CbGpPWpGaD
Paricalcitol—Myalgia—Simvastatin—atherosclerosis	0.000933	0.00247	CcSEcCtD
Paricalcitol—Chest pain—Simvastatin—atherosclerosis	0.000933	0.00247	CcSEcCtD
Paricalcitol—Arthralgia—Simvastatin—atherosclerosis	0.000933	0.00247	CcSEcCtD
Paricalcitol—Infection—Ezetimibe—atherosclerosis	0.000932	0.00247	CcSEcCtD
Paricalcitol—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00093	0.00247	CcSEcCtD
Paricalcitol—Anxiety—Simvastatin—atherosclerosis	0.00093	0.00247	CcSEcCtD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—IFNG—atherosclerosis	0.000927	0.0038	CbGpPWpGaD
Paricalcitol—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000923	0.00245	CcSEcCtD
Paricalcitol—Discomfort—Simvastatin—atherosclerosis	0.000922	0.00244	CcSEcCtD
Paricalcitol—Nervous system disorder—Ezetimibe—atherosclerosis	0.00092	0.00244	CcSEcCtD
Paricalcitol—Angioedema—Niacin—atherosclerosis	0.00092	0.00244	CcSEcCtD
Paricalcitol—Ill-defined disorder—Pravastatin—atherosclerosis	0.000919	0.00244	CcSEcCtD
Paricalcitol—Anaemia—Pravastatin—atherosclerosis	0.000916	0.00243	CcSEcCtD
Paricalcitol—Anorexia—Lovastatin—atherosclerosis	0.000912	0.00242	CcSEcCtD
Paricalcitol—Skin disorder—Ezetimibe—atherosclerosis	0.000911	0.00242	CcSEcCtD
Paricalcitol—Angioedema—Pravastatin—atherosclerosis	0.000905	0.0024	CcSEcCtD
Paricalcitol—Vertigo—Niacin—atherosclerosis	0.000904	0.0024	CcSEcCtD
Paricalcitol—Syncope—Niacin—atherosclerosis	0.000903	0.00239	CcSEcCtD
Paricalcitol—Confusional state—Simvastatin—atherosclerosis	0.000902	0.00239	CcSEcCtD
Paricalcitol—Leukopenia—Niacin—atherosclerosis	0.000901	0.00239	CcSEcCtD
Paricalcitol—Urticaria—Rosuvastatin—atherosclerosis	0.000897	0.00238	CcSEcCtD
Paricalcitol—Oedema—Simvastatin—atherosclerosis	0.000895	0.00237	CcSEcCtD
Paricalcitol—Malaise—Pravastatin—atherosclerosis	0.000894	0.00237	CcSEcCtD
Paricalcitol—Abdominal pain—Rosuvastatin—atherosclerosis	0.000892	0.00236	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.000891	0.00366	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.000891	0.00366	CbGpPWpGaD
Paricalcitol—Vertigo—Pravastatin—atherosclerosis	0.00089	0.00236	CcSEcCtD
Paricalcitol—Palpitations—Niacin—atherosclerosis	0.000889	0.00236	CcSEcCtD
Paricalcitol—Infection—Simvastatin—atherosclerosis	0.000889	0.00236	CcSEcCtD
Paricalcitol—Leukopenia—Pravastatin—atherosclerosis	0.000887	0.00235	CcSEcCtD
Paricalcitol—Loss of consciousness—Niacin—atherosclerosis	0.000885	0.00235	CcSEcCtD
Paricalcitol—Cough—Niacin—atherosclerosis	0.000878	0.00233	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000871	0.00231	CcSEcCtD
Paricalcitol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG1—atherosclerosis	0.000871	0.00357	CbGpPWpGaD
Paricalcitol—Insomnia—Lovastatin—atherosclerosis	0.000865	0.00229	CcSEcCtD
Paricalcitol—Cough—Pravastatin—atherosclerosis	0.000865	0.00229	CcSEcCtD
Paricalcitol—Paraesthesia—Lovastatin—atherosclerosis	0.000859	0.00228	CcSEcCtD
Paricalcitol—Arthralgia—Niacin—atherosclerosis	0.000857	0.00227	CcSEcCtD
Paricalcitol—Myalgia—Niacin—atherosclerosis	0.000857	0.00227	CcSEcCtD
Paricalcitol—Hypertension—Pravastatin—atherosclerosis	0.000856	0.00227	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000855	0.00227	CcSEcCtD
Paricalcitol—Anorexia—Simvastatin—atherosclerosis	0.000853	0.00226	CcSEcCtD
Paricalcitol—Dyspnoea—Lovastatin—atherosclerosis	0.000853	0.00226	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000851	0.00226	CcSEcCtD
Paricalcitol—Insomnia—Ezetimibe—atherosclerosis	0.000848	0.00225	CcSEcCtD
Paricalcitol—Arthralgia—Pravastatin—atherosclerosis	0.000844	0.00224	CcSEcCtD
Paricalcitol—Myalgia—Pravastatin—atherosclerosis	0.000844	0.00224	CcSEcCtD
Paricalcitol—Chest pain—Pravastatin—atherosclerosis	0.000844	0.00224	CcSEcCtD
Paricalcitol—Paraesthesia—Ezetimibe—atherosclerosis	0.000842	0.00223	CcSEcCtD
Paricalcitol—Dyspepsia—Lovastatin—atherosclerosis	0.000842	0.00223	CcSEcCtD
Paricalcitol—Anxiety—Pravastatin—atherosclerosis	0.000841	0.00223	CcSEcCtD
Paricalcitol—Dry mouth—Niacin—atherosclerosis	0.000838	0.00222	CcSEcCtD
Paricalcitol—Dyspnoea—Ezetimibe—atherosclerosis	0.000836	0.00222	CcSEcCtD
Paricalcitol—Discomfort—Pravastatin—atherosclerosis	0.000834	0.00221	CcSEcCtD
Paricalcitol—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000831	0.0022	CcSEcCtD
Paricalcitol—Decreased appetite—Lovastatin—atherosclerosis	0.000831	0.0022	CcSEcCtD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—IL1B—atherosclerosis	0.000827	0.00339	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—ESR1—atherosclerosis	0.000826	0.00339	CbGpPWpGaD
Paricalcitol—Dyspepsia—Ezetimibe—atherosclerosis	0.000826	0.00219	CcSEcCtD
Paricalcitol—Fatigue—Lovastatin—atherosclerosis	0.000825	0.00219	CcSEcCtD
Paricalcitol—Oedema—Niacin—atherosclerosis	0.000821	0.00218	CcSEcCtD
Paricalcitol—Constipation—Lovastatin—atherosclerosis	0.000818	0.00217	CcSEcCtD
Paricalcitol—Pain—Lovastatin—atherosclerosis	0.000818	0.00217	CcSEcCtD
Paricalcitol—Confusional state—Pravastatin—atherosclerosis	0.000815	0.00216	CcSEcCtD
Paricalcitol—Decreased appetite—Ezetimibe—atherosclerosis	0.000815	0.00216	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000815	0.00216	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00081	0.00215	CcSEcCtD
Paricalcitol—Asthenia—Rosuvastatin—atherosclerosis	0.00081	0.00215	CcSEcCtD
Paricalcitol—Insomnia—Simvastatin—atherosclerosis	0.000809	0.00214	CcSEcCtD
Paricalcitol—Oedema—Pravastatin—atherosclerosis	0.000809	0.00214	CcSEcCtD
Paricalcitol—Fatigue—Ezetimibe—atherosclerosis	0.000809	0.00214	CcSEcCtD
Paricalcitol—Shock—Niacin—atherosclerosis	0.000808	0.00214	CcSEcCtD
Paricalcitol—Infection—Pravastatin—atherosclerosis	0.000803	0.00213	CcSEcCtD
Paricalcitol—Paraesthesia—Simvastatin—atherosclerosis	0.000803	0.00213	CcSEcCtD
Paricalcitol—Pain—Ezetimibe—atherosclerosis	0.000802	0.00213	CcSEcCtD
Paricalcitol—Constipation—Ezetimibe—atherosclerosis	0.000802	0.00213	CcSEcCtD
Paricalcitol—Pruritus—Rosuvastatin—atherosclerosis	0.000798	0.00212	CcSEcCtD
Paricalcitol—Skin disorder—Niacin—atherosclerosis	0.000798	0.00212	CcSEcCtD
Paricalcitol—Dyspnoea—Simvastatin—atherosclerosis	0.000798	0.00211	CcSEcCtD
Paricalcitol—Hyperhidrosis—Niacin—atherosclerosis	0.000794	0.00211	CcSEcCtD
Paricalcitol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP7A1—atherosclerosis	0.00079	0.00324	CbGpPWpGaD
Paricalcitol—Feeling abnormal—Lovastatin—atherosclerosis	0.000788	0.00209	CcSEcCtD
Paricalcitol—Dyspepsia—Simvastatin—atherosclerosis	0.000787	0.00209	CcSEcCtD
Paricalcitol—Anorexia—Niacin—atherosclerosis	0.000783	0.00208	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000782	0.00207	CcSEcCtD
Paricalcitol—Hyperhidrosis—Pravastatin—atherosclerosis	0.000782	0.00207	CcSEcCtD
Paricalcitol—Decreased appetite—Simvastatin—atherosclerosis	0.000778	0.00206	CcSEcCtD
Paricalcitol—Feeling abnormal—Ezetimibe—atherosclerosis	0.000773	0.00205	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000772	0.00205	CcSEcCtD
Paricalcitol—Diarrhoea—Rosuvastatin—atherosclerosis	0.000772	0.00205	CcSEcCtD
Paricalcitol—Fatigue—Simvastatin—atherosclerosis	0.000771	0.00204	CcSEcCtD
Paricalcitol—Anorexia—Pravastatin—atherosclerosis	0.000771	0.00204	CcSEcCtD
Paricalcitol—Hypotension—Niacin—atherosclerosis	0.000768	0.00203	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000767	0.00203	CcSEcCtD
Paricalcitol—Pain—Simvastatin—atherosclerosis	0.000765	0.00203	CcSEcCtD
Paricalcitol—Constipation—Simvastatin—atherosclerosis	0.000765	0.00203	CcSEcCtD
Paricalcitol—Urticaria—Lovastatin—atherosclerosis	0.00076	0.00201	CcSEcCtD
Paricalcitol—Abdominal pain—Lovastatin—atherosclerosis	0.000756	0.002	CcSEcCtD
Paricalcitol—Body temperature increased—Lovastatin—atherosclerosis	0.000756	0.002	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000748	0.00198	CcSEcCtD
Paricalcitol—Dizziness—Rosuvastatin—atherosclerosis	0.000746	0.00198	CcSEcCtD
Paricalcitol—Urticaria—Ezetimibe—atherosclerosis	0.000745	0.00198	CcSEcCtD
Paricalcitol—Insomnia—Niacin—atherosclerosis	0.000743	0.00197	CcSEcCtD
Paricalcitol—Body temperature increased—Ezetimibe—atherosclerosis	0.000742	0.00197	CcSEcCtD
Paricalcitol—Abdominal pain—Ezetimibe—atherosclerosis	0.000742	0.00197	CcSEcCtD
Paricalcitol—Paraesthesia—Niacin—atherosclerosis	0.000738	0.00196	CcSEcCtD
Paricalcitol—Feeling abnormal—Simvastatin—atherosclerosis	0.000737	0.00195	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000737	0.00195	CcSEcCtD
Paricalcitol—Dyspnoea—Niacin—atherosclerosis	0.000732	0.00194	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000732	0.00194	CcSEcCtD
Paricalcitol—Insomnia—Pravastatin—atherosclerosis	0.000731	0.00194	CcSEcCtD
Paricalcitol—Somnolence—Niacin—atherosclerosis	0.00073	0.00194	CcSEcCtD
Paricalcitol—CYP3A4—liver—atherosclerosis	0.000727	0.0113	CbGeAlD
Paricalcitol—Paraesthesia—Pravastatin—atherosclerosis	0.000726	0.00193	CcSEcCtD
Paricalcitol—Dyspepsia—Niacin—atherosclerosis	0.000723	0.00192	CcSEcCtD
Paricalcitol—Dyspnoea—Pravastatin—atherosclerosis	0.000721	0.00191	CcSEcCtD
Paricalcitol—Decreased appetite—Niacin—atherosclerosis	0.000714	0.00189	CcSEcCtD
Paricalcitol—Dyspepsia—Pravastatin—atherosclerosis	0.000712	0.00189	CcSEcCtD
Paricalcitol—Rash—Rosuvastatin—atherosclerosis	0.000712	0.00189	CcSEcCtD
Paricalcitol—Dermatitis—Rosuvastatin—atherosclerosis	0.000711	0.00188	CcSEcCtD
Paricalcitol—Urticaria—Simvastatin—atherosclerosis	0.000711	0.00188	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Niacin—atherosclerosis	0.000709	0.00188	CcSEcCtD
Paricalcitol—Abdominal pain—Simvastatin—atherosclerosis	0.000707	0.00187	CcSEcCtD
Paricalcitol—Body temperature increased—Simvastatin—atherosclerosis	0.000707	0.00187	CcSEcCtD
Paricalcitol—Headache—Rosuvastatin—atherosclerosis	0.000707	0.00187	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.000705	0.00289	CbGpPWpGaD
Paricalcitol—Hypersensitivity—Lovastatin—atherosclerosis	0.000705	0.00187	CcSEcCtD
Paricalcitol—Decreased appetite—Pravastatin—atherosclerosis	0.000703	0.00186	CcSEcCtD
Paricalcitol—Pain—Niacin—atherosclerosis	0.000702	0.00186	CcSEcCtD
Paricalcitol—Fatigue—Pravastatin—atherosclerosis	0.000697	0.00185	CcSEcCtD
Paricalcitol—Constipation—Pravastatin—atherosclerosis	0.000692	0.00183	CcSEcCtD
Paricalcitol—Pain—Pravastatin—atherosclerosis	0.000692	0.00183	CcSEcCtD
Paricalcitol—Hypersensitivity—Ezetimibe—atherosclerosis	0.000691	0.00183	CcSEcCtD
Paricalcitol—CYP24A1—Biological oxidations—GSTM1—atherosclerosis	0.000687	0.00282	CbGpPWpGaD
Paricalcitol—Asthenia—Lovastatin—atherosclerosis	0.000686	0.00182	CcSEcCtD
Paricalcitol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—atherosclerosis	0.000684	0.0028	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—atherosclerosis	0.000679	0.00278	CbGpPWpGaD
Paricalcitol—CYP24A1—Metapathway biotransformation—GSTM1—atherosclerosis	0.000677	0.00278	CbGpPWpGaD
Paricalcitol—Pruritus—Lovastatin—atherosclerosis	0.000677	0.00179	CcSEcCtD
Paricalcitol—Asthenia—Ezetimibe—atherosclerosis	0.000673	0.00178	CcSEcCtD
Paricalcitol—UGT1A4—NRF2 pathway—HMOX1—atherosclerosis	0.000672	0.00276	CbGpPWpGaD
Paricalcitol—Gastrointestinal pain—Niacin—atherosclerosis	0.000672	0.00178	CcSEcCtD
Paricalcitol—Nausea—Rosuvastatin—atherosclerosis	0.00067	0.00178	CcSEcCtD
Paricalcitol—Feeling abnormal—Pravastatin—atherosclerosis	0.000666	0.00177	CcSEcCtD
Paricalcitol—Pruritus—Ezetimibe—atherosclerosis	0.000664	0.00176	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.000663	0.00272	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.000663	0.00272	CbGpPWpGaD
Paricalcitol—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000661	0.00175	CcSEcCtD
Paricalcitol—VDR—Retinoic acid receptors-mediated signaling—AKT1—atherosclerosis	0.000659	0.0027	CbGpPWpGaD
Paricalcitol—Hypersensitivity—Simvastatin—atherosclerosis	0.000659	0.00175	CcSEcCtD
Paricalcitol—Diarrhoea—Lovastatin—atherosclerosis	0.000654	0.00173	CcSEcCtD
Paricalcitol—Urticaria—Niacin—atherosclerosis	0.000653	0.00173	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.00065	0.00267	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—GPX1—atherosclerosis	0.00065	0.00267	CbGpPWpGaD
Paricalcitol—Body temperature increased—Niacin—atherosclerosis	0.000649	0.00172	CcSEcCtD
Paricalcitol—Abdominal pain—Niacin—atherosclerosis	0.000649	0.00172	CcSEcCtD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—TGFB1—atherosclerosis	0.000643	0.00264	CbGpPWpGaD
Paricalcitol—Urticaria—Pravastatin—atherosclerosis	0.000642	0.0017	CcSEcCtD
Paricalcitol—Asthenia—Simvastatin—atherosclerosis	0.000642	0.0017	CcSEcCtD
Paricalcitol—Diarrhoea—Ezetimibe—atherosclerosis	0.000642	0.0017	CcSEcCtD
Paricalcitol—Body temperature increased—Pravastatin—atherosclerosis	0.000639	0.00169	CcSEcCtD
Paricalcitol—Abdominal pain—Pravastatin—atherosclerosis	0.000639	0.00169	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.000639	0.00262	CbGpPWpGaD
Paricalcitol—Pruritus—Simvastatin—atherosclerosis	0.000633	0.00168	CcSEcCtD
Paricalcitol—Dizziness—Lovastatin—atherosclerosis	0.000632	0.00168	CcSEcCtD
Paricalcitol—VDR—Direct p53 effectors—SPP1—atherosclerosis	0.000631	0.00259	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—GSTM1—atherosclerosis	0.000626	0.00257	CbGpPWpGaD
Paricalcitol—Dizziness—Ezetimibe—atherosclerosis	0.00062	0.00164	CcSEcCtD
Paricalcitol—Diarrhoea—Simvastatin—atherosclerosis	0.000612	0.00162	CcSEcCtD
Paricalcitol—Vomiting—Lovastatin—atherosclerosis	0.000608	0.00161	CcSEcCtD
Paricalcitol—Hypersensitivity—Niacin—atherosclerosis	0.000605	0.0016	CcSEcCtD
Paricalcitol—UGT1A4—NRF2 pathway—AGER—atherosclerosis	0.000604	0.00248	CbGpPWpGaD
Paricalcitol—Rash—Lovastatin—atherosclerosis	0.000603	0.0016	CcSEcCtD
Paricalcitol—Dermatitis—Lovastatin—atherosclerosis	0.000602	0.0016	CcSEcCtD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—TNF—atherosclerosis	0.0006	0.00246	CbGpPWpGaD
Paricalcitol—Headache—Lovastatin—atherosclerosis	0.000599	0.00159	CcSEcCtD
Paricalcitol—Vomiting—Ezetimibe—atherosclerosis	0.000596	0.00158	CcSEcCtD
Paricalcitol—Hypersensitivity—Pravastatin—atherosclerosis	0.000596	0.00158	CcSEcCtD
Paricalcitol—Dizziness—Simvastatin—atherosclerosis	0.000592	0.00157	CcSEcCtD
Paricalcitol—Rash—Ezetimibe—atherosclerosis	0.000591	0.00157	CcSEcCtD
Paricalcitol—Dermatitis—Ezetimibe—atherosclerosis	0.000591	0.00157	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.000591	0.00242	CbGpPWpGaD
Paricalcitol—Asthenia—Niacin—atherosclerosis	0.000589	0.00156	CcSEcCtD
Paricalcitol—Headache—Ezetimibe—atherosclerosis	0.000588	0.00156	CcSEcCtD
Paricalcitol—Pruritus—Niacin—atherosclerosis	0.000581	0.00154	CcSEcCtD
Paricalcitol—Asthenia—Pravastatin—atherosclerosis	0.00058	0.00154	CcSEcCtD
Paricalcitol—Pruritus—Pravastatin—atherosclerosis	0.000572	0.00152	CcSEcCtD
Paricalcitol—Vomiting—Simvastatin—atherosclerosis	0.000569	0.00151	CcSEcCtD
Paricalcitol—Nausea—Lovastatin—atherosclerosis	0.000568	0.00151	CcSEcCtD
Paricalcitol—Rash—Simvastatin—atherosclerosis	0.000564	0.0015	CcSEcCtD
Paricalcitol—Dermatitis—Simvastatin—atherosclerosis	0.000564	0.00149	CcSEcCtD
Paricalcitol—Diarrhoea—Niacin—atherosclerosis	0.000562	0.00149	CcSEcCtD
Paricalcitol—Headache—Simvastatin—atherosclerosis	0.00056	0.00149	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.00056	0.0023	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.00056	0.0023	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.00056	0.0023	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.00056	0.0023	CbGpPWpGaD
Paricalcitol—Nausea—Ezetimibe—atherosclerosis	0.000557	0.00148	CcSEcCtD
Paricalcitol—Diarrhoea—Pravastatin—atherosclerosis	0.000553	0.00147	CcSEcCtD
Paricalcitol—VDR—Direct p53 effectors—CAV1—atherosclerosis	0.000553	0.00227	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.000553	0.00227	CbGpPWpGaD
Paricalcitol—UGT1A4—Biological oxidations—GSTM1—atherosclerosis	0.000549	0.00225	CbGpPWpGaD
Paricalcitol—Dizziness—Niacin—atherosclerosis	0.000543	0.00144	CcSEcCtD
Paricalcitol—CYP3A4—Estrogen metabolism—GSTM1—atherosclerosis	0.000542	0.00222	CbGpPWpGaD
Paricalcitol—UGT1A4—Metapathway biotransformation—GSTM1—atherosclerosis	0.000542	0.00222	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—PDGFB—atherosclerosis	0.000539	0.00221	CbGpPWpGaD
Paricalcitol—Dizziness—Pravastatin—atherosclerosis	0.000535	0.00142	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.000534	0.00219	CbGpPWpGaD
Paricalcitol—Nausea—Simvastatin—atherosclerosis	0.000531	0.00141	CcSEcCtD
Paricalcitol—Vomiting—Niacin—atherosclerosis	0.000522	0.00138	CcSEcCtD
Paricalcitol—Rash—Niacin—atherosclerosis	0.000518	0.00137	CcSEcCtD
Paricalcitol—Dermatitis—Niacin—atherosclerosis	0.000517	0.00137	CcSEcCtD
Paricalcitol—Headache—Niacin—atherosclerosis	0.000515	0.00136	CcSEcCtD
Paricalcitol—Vomiting—Pravastatin—atherosclerosis	0.000514	0.00136	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.000512	0.0021	CbGpPWpGaD
Paricalcitol—Rash—Pravastatin—atherosclerosis	0.00051	0.00135	CcSEcCtD
Paricalcitol—Dermatitis—Pravastatin—atherosclerosis	0.000509	0.00135	CcSEcCtD
Paricalcitol—Headache—Pravastatin—atherosclerosis	0.000507	0.00134	CcSEcCtD
Paricalcitol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP7A1—atherosclerosis	0.000501	0.00206	CbGpPWpGaD
Paricalcitol—CYP3A4—Oxidation by Cytochrome P450—CYP7A1—atherosclerosis	0.000495	0.00203	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.000493	0.00202	CbGpPWpGaD
Paricalcitol—Nausea—Niacin—atherosclerosis	0.000488	0.00129	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—LDLRAP1—atherosclerosis	0.000487	0.002	CbGpPWpGaD
Paricalcitol—Nausea—Pravastatin—atherosclerosis	0.00048	0.00127	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.000476	0.00195	CbGpPWpGaD
Paricalcitol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	0.000463	0.0019	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PLTP—atherosclerosis	0.000458	0.00188	CbGpPWpGaD
Paricalcitol—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	0.000457	0.00188	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—MMP2—atherosclerosis	0.000447	0.00183	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—SERPINE1—atherosclerosis	0.000438	0.0018	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.000424	0.00174	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.000422	0.00173	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.000419	0.00172	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.000409	0.00168	CbGpPWpGaD
Paricalcitol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	0.000408	0.00167	CbGpPWpGaD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	0.000406	0.00167	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—LTA4H—atherosclerosis	0.000397	0.00163	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ABCG8—atherosclerosis	0.000397	0.00163	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.000392	0.00161	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—LDLRAP1—atherosclerosis	0.000389	0.0016	CbGpPWpGaD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	0.000376	0.00154	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	0.00037	0.00152	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PLTP—atherosclerosis	0.000366	0.0015	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—PARP1—atherosclerosis	0.00036	0.00147	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—ESR2—atherosclerosis	0.000341	0.0014	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	0.00033	0.00135	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—LTA4H—atherosclerosis	0.000317	0.0013	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ABCG8—atherosclerosis	0.000317	0.0013	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ABCG1—atherosclerosis	0.000314	0.00129	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—AKT1—atherosclerosis	0.000298	0.00122	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—FABP4—atherosclerosis	0.000295	0.00121	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—LCAT—atherosclerosis	0.000295	0.00121	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—APOA4—atherosclerosis	0.00029	0.00119	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CYP7A1—atherosclerosis	0.000285	0.00117	CbGpPWpGaD
Paricalcitol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	0.000283	0.00116	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	0.000271	0.00111	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CYP27A1—atherosclerosis	0.000263	0.00108	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	0.000259	0.00106	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—TGFB1—atherosclerosis	0.000255	0.00105	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	0.000253	0.00104	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ABCG1—atherosclerosis	0.000251	0.00103	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—APOA2—atherosclerosis	0.000249	0.00102	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PLA2G2A—atherosclerosis	0.000249	0.00102	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ALOX15—atherosclerosis	0.000249	0.00102	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ALOX5AP—atherosclerosis	0.000249	0.00102	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ABCG5—atherosclerosis	0.000246	0.00101	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	0.000246	0.00101	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—LPA—atherosclerosis	0.000238	0.000975	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—FABP4—atherosclerosis	0.000236	0.000967	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—LCAT—atherosclerosis	0.000236	0.000967	CbGpPWpGaD
Paricalcitol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	0.000234	0.000958	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—APOA4—atherosclerosis	0.000232	0.00095	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—BGN—atherosclerosis	0.00023	0.000945	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	0.000229	0.000938	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—APOA5—atherosclerosis	0.000228	0.000935	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—PPARA—atherosclerosis	0.000228	0.000935	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CYP7A1—atherosclerosis	0.000227	0.000933	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	0.000221	0.000908	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PLA2G1B—atherosclerosis	0.000219	0.0009	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	0.000217	0.00089	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—CYP7A1—atherosclerosis	0.000216	0.000885	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	0.000215	0.000882	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	0.000215	0.00088	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—CYP7A1—atherosclerosis	0.000213	0.000873	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ALOX5—atherosclerosis	0.000212	0.000869	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CYP27A1—atherosclerosis	0.00021	0.000862	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—ESR1—atherosclerosis	0.000207	0.000847	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—CYP27A1—atherosclerosis	0.0002	0.000818	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PLA2G2A—atherosclerosis	0.000199	0.000817	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—APOA2—atherosclerosis	0.000199	0.000817	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ALOX5AP—atherosclerosis	0.000199	0.000817	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ALOX15—atherosclerosis	0.000199	0.000817	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ABCG5—atherosclerosis	0.000197	0.000807	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—CYP27A1—atherosclerosis	0.000197	0.000807	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	0.000196	0.000803	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—HSPA1B—atherosclerosis	0.000194	0.000797	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—LPA—atherosclerosis	0.00019	0.00078	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—NAMPT—atherosclerosis	0.00019	0.00078	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	0.000189	0.000775	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—LIPC—atherosclerosis	0.000189	0.000775	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—PPARG—atherosclerosis	0.000188	0.000773	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—APOC3—atherosclerosis	0.000188	0.00077	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—LDLR—atherosclerosis	0.000187	0.000765	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—BGN—atherosclerosis	0.000184	0.000755	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CETP—atherosclerosis	0.000182	0.000748	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—APOA5—atherosclerosis	0.000182	0.000748	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PLA2G1B—atherosclerosis	0.000175	0.00072	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—SCARB1—atherosclerosis	0.000175	0.000716	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—PARP1—atherosclerosis	0.000173	0.00071	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	0.00017	0.000697	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—SERPINE1—atherosclerosis	0.00017	0.000696	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ALOX5—atherosclerosis	0.000169	0.000695	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—HMGCR—atherosclerosis	0.000165	0.000676	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—ESR2—atherosclerosis	0.000164	0.000672	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NAMPT—atherosclerosis	0.000152	0.000623	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—LIPC—atherosclerosis	0.000151	0.000619	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—APOC3—atherosclerosis	0.00015	0.000616	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—LDLR—atherosclerosis	0.000149	0.000612	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	0.000149	0.00061	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ABCA1—atherosclerosis	0.000147	0.000603	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CETP—atherosclerosis	0.000146	0.000598	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—SCARB1—atherosclerosis	0.00014	0.000572	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—SIRT1—atherosclerosis	0.000132	0.000541	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—HMGCR—atherosclerosis	0.000132	0.00054	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—HMOX1—atherosclerosis	0.000126	0.000517	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—APOB—atherosclerosis	0.000121	0.000495	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GSTM1—atherosclerosis	0.000117	0.000482	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ABCA1—atherosclerosis	0.000117	0.000482	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—LPL—atherosclerosis	0.000115	0.000473	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GPX1—atherosclerosis	0.000112	0.000461	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—PPARA—atherosclerosis	0.00011	0.00045	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CD36—atherosclerosis	0.00011	0.000449	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—MTHFR—atherosclerosis	0.000104	0.000426	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PPARA—atherosclerosis	0.000102	0.000418	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—HMOX1—atherosclerosis	0.000101	0.000413	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—ESR1—atherosclerosis	9.94e-05	0.000408	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—AGT—atherosclerosis	9.86e-05	0.000405	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—APOE—atherosclerosis	9.66e-05	0.000396	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—APOB—atherosclerosis	9.65e-05	0.000396	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CAV1—atherosclerosis	9.58e-05	0.000393	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—APOA1—atherosclerosis	9.55e-05	0.000392	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GSTM1—atherosclerosis	9.39e-05	0.000385	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—LPL—atherosclerosis	9.22e-05	0.000378	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—PPARG—atherosclerosis	9.07e-05	0.000372	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GPX1—atherosclerosis	8.99e-05	0.000369	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	8.91e-05	0.000366	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	8.79e-05	0.000361	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CD36—atherosclerosis	8.76e-05	0.000359	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PIK3CG—atherosclerosis	8.72e-05	0.000358	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PPARG—atherosclerosis	8.42e-05	0.000345	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—MTHFR—atherosclerosis	8.3e-05	0.00034	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—INS—atherosclerosis	8.26e-05	0.000339	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—SERPINE1—atherosclerosis	8.17e-05	0.000335	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PPARA—atherosclerosis	8.14e-05	0.000334	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—AGT—atherosclerosis	7.89e-05	0.000323	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—APOE—atherosclerosis	7.73e-05	0.000317	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CAV1—atherosclerosis	7.65e-05	0.000314	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—APOA1—atherosclerosis	7.64e-05	0.000313	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ALB—atherosclerosis	7.57e-05	0.00031	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—NOS3—atherosclerosis	7.24e-05	0.000297	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PIK3CG—atherosclerosis	6.97e-05	0.000286	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PPARG—atherosclerosis	6.73e-05	0.000276	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PTGS2—atherosclerosis	6.62e-05	0.000272	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—INS—atherosclerosis	6.6e-05	0.000271	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	6.32e-05	0.000259	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ALB—atherosclerosis	6.05e-05	0.000248	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PLTP—atherosclerosis	5.94e-05	0.000244	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NOS3—atherosclerosis	5.79e-05	0.000237	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—MAPK3—atherosclerosis	5.32e-05	0.000218	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PTGS2—atherosclerosis	5.29e-05	0.000217	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—LTA4H—atherosclerosis	5.15e-05	0.000211	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ABCG8—atherosclerosis	5.15e-05	0.000211	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ABCG1—atherosclerosis	4.07e-05	0.000167	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—LCAT—atherosclerosis	3.83e-05	0.000157	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—FABP4—atherosclerosis	3.83e-05	0.000157	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—APOA4—atherosclerosis	3.76e-05	0.000154	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CYP7A1—atherosclerosis	3.69e-05	0.000151	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—AKT1—atherosclerosis	3.59e-05	0.000147	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CYP27A1—atherosclerosis	3.41e-05	0.00014	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—AKT1—atherosclerosis	3.33e-05	0.000136	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	3.24e-05	0.000133	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	3.24e-05	0.000133	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—APOA2—atherosclerosis	3.24e-05	0.000133	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ALOX15—atherosclerosis	3.24e-05	0.000133	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ABCG5—atherosclerosis	3.2e-05	0.000131	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—LPA—atherosclerosis	3.09e-05	0.000127	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—BGN—atherosclerosis	2.99e-05	0.000123	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—APOA5—atherosclerosis	2.96e-05	0.000121	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	2.85e-05	0.000117	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ALOX5—atherosclerosis	2.75e-05	0.000113	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—AKT1—atherosclerosis	2.66e-05	0.000109	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NAMPT—atherosclerosis	2.47e-05	0.000101	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—LIPC—atherosclerosis	2.45e-05	0.000101	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—APOC3—atherosclerosis	2.44e-05	9.99e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—LDLR—atherosclerosis	2.42e-05	9.93e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CETP—atherosclerosis	2.37e-05	9.7e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SCARB1—atherosclerosis	2.27e-05	9.29e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—HMGCR—atherosclerosis	2.14e-05	8.77e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ABCA1—atherosclerosis	1.91e-05	7.82e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.64e-05	6.71e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—APOB—atherosclerosis	1.57e-05	6.43e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.52e-05	6.25e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—LPL—atherosclerosis	1.5e-05	6.14e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GPX1—atherosclerosis	1.46e-05	5.99e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CD36—atherosclerosis	1.42e-05	5.83e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.35e-05	5.52e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PPARA—atherosclerosis	1.32e-05	5.42e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—AGT—atherosclerosis	1.28e-05	5.25e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—APOE—atherosclerosis	1.25e-05	5.14e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CAV1—atherosclerosis	1.24e-05	5.1e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—APOA1—atherosclerosis	1.24e-05	5.08e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.13e-05	4.64e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PPARG—atherosclerosis	1.09e-05	4.48e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—INS—atherosclerosis	1.07e-05	4.39e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ALB—atherosclerosis	9.82e-06	4.03e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NOS3—atherosclerosis	9.4e-06	3.85e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PTGS2—atherosclerosis	8.59e-06	3.52e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—AKT1—atherosclerosis	4.32e-06	1.77e-05	CbGpPWpGaD
